LINCOLN
Lincoln Pharma notched 42% higher Q4 EPS of Rs 6.3 and 21% higher FY21 EPS of Rs 31 is the cheapest pharma share. With likely EPS of Rs 38, the share trades at a forward P/E of 9x.
Lincoln Pharma has entered the fast track. The Company is now debt free and has aggressive expansion programs. Rising exports and strong financials make this share a good buy. Will be a great buy near 315-320 levels.
Lincoln Pharma has entered the fast track. The Company is now debt free and has aggressive expansion programs. Rising exports and strong financials make this share a good buy. Will be a great buy near 315-320 levels.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.